Vidac Pharma to Present Company Progress at European Life Sciences CEO Forum

Reuters

02/16

Vidac Pharma to Present Company Progress at European Life Sciences CEO Forum

Vidac Pharma Holding plc will participate in the 19th Annual European Life Sciences CEO Forum, organized by Sachs Associates, on March 4-5, 2026, at the Hilton Zurich Airport Hotel. Dr. Max Herzberg, Chairman and Chief Executive Officer of Vidac Pharma, is scheduled to deliver a 20-minute presentation, including a Q&A session, on March 4, 2026, at 14:40 (Track C, Room Berne). During the presentation, Dr. Herzberg will provide updates on the company’s recent clinical advancements, strategic developments, and the ongoing expansion of Vidac’s oncology pipeline.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vidac Pharma Holding plc published the original content used to generate this news brief via pressetext (Ref. ID: 202602160100PRESSTXTEUPR____5870204DE1DE384988D7A85DDCB8E5F) on February 16, 2026, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2611263104"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2611263104\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2611263104?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-16 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2611263104","market":"nz","top_or_hot":-1,"title":"Vidac Pharma to Present Company Progress at European Life Sciences CEO Forum","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Vidac Pharma to Present Company Progress at European Life Sciences CEO Forum\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Vidac Pharma Holding plc will participate in the 19th Annual European Life Sciences CEO Forum, organized by Sachs Associates, on March 4-5, 2026, at the Hilton Zurich Airport Hotel. Dr. Max Herzberg, Chairman and Chief Executive Officer of Vidac Pharma, is scheduled to deliver a 20-minute presentation, including a Q&amp;A session, on March 4, 2026, at 14:40 (Track C, Room Berne). During the presentation, Dr. Herzberg will provide updates on the company’s recent clinical advancements, strategic developments, and the ongoing expansion of Vidac’s oncology pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vidac Pharma Holding plc published the original content used to generate this news brief via pressetext (Ref. ID: 202602160100PRESSTXTEUPR____5870204DE1DE384988D7A85DDCB8E5F) on February 16, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vidac Pharma to Present Company Progress at European Life Sciences CEO Forum</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVidac Pharma to Present Company Progress at European Life Sciences CEO Forum\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-16 16:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Vidac Pharma to Present Company Progress at European Life Sciences CEO Forum\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Vidac Pharma Holding plc will participate in the 19th Annual European Life Sciences CEO Forum, organized by Sachs Associates, on March 4-5, 2026, at the Hilton Zurich Airport Hotel. Dr. Max Herzberg, Chairman and Chief Executive Officer of Vidac Pharma, is scheduled to deliver a 20-minute presentation, including a Q&amp;A session, on March 4, 2026, at 14:40 (Track C, Room Berne). During the presentation, Dr. Herzberg will provide updates on the company’s recent clinical advancements, strategic developments, and the ongoing expansion of Vidac’s oncology pipeline.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vidac Pharma Holding plc published the original content used to generate this news brief via pressetext (Ref. ID: 202602160100PRESSTXTEUPR____5870204DE1DE384988D7A85DDCB8E5F) on February 16, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HLT","symbol_name":"希尔顿酒店","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260216:nNDL3CV1XN:1","article_id":"2611263104","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2611263104","pubTimestamp":1771231828,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Vidac Pharma Holding plc will participate in the 19th Annual European Life Sciences CEO Forum, organized by Sachs Associates, on March 4-5, 2026, at the Hilton Zurich Airport Hotel. Dr. Max Herzberg, Chairman and Chief Executive Officer of Vidac Pharma, is scheduled to deliver a 20-minute presentation, including a Q&A session, on March 4, 2026, at 14:40 . During the presentation, Dr. Herzberg will provide updates on the company’s recent clinical advancements, strategic developments, and the ongoing expansion of Vidac’s oncology pipeline.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HLT":"希尔顿酒店","LU2764263039.SGD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (SGDHDG) ACC","LU0823411888.USD":"法巴消费创新基金 Cap","LU2764262908.HKD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (HKD) ACC","LU2720916845.USD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (USD) ACC","LU2764263203.CNY":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (CNYHDG) ACC","LU0154245673.USD":"BNP PARIBAS US MID CAP \"C\" (USD) INC","BK4566":"资本集团","BK4588":"碎股","BK4585":"ETF&股票定投概念","BK4142":"酒店、度假村与豪华游轮","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0154245756.USD":"BNP PARIBAS US MID CAP \"C\" (USD) ACC"},"translate_title":"Vidac Pharma将在欧洲生命科学首席执行官论坛上介绍公司进展","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HLT":0.9},"content_text":"Vidac Pharma to Present Company Progress at European Life Sciences CEO Forum\n    \n\n        Vidac Pharma Holding plc will participate in the 19th Annual European Life Sciences CEO Forum, organized by Sachs Associates, on March 4-5, 2026, at the Hilton Zurich Airport Hotel. Dr. Max Herzberg, Chairman and Chief Executive Officer of Vidac Pharma, is scheduled to deliver a 20-minute presentation, including a Q&A session, on March 4, 2026, at 14:40 (Track C, Room Berne). During the presentation, Dr. Herzberg will provide updates on the company’s recent clinical advancements, strategic developments, and the ongoing expansion of Vidac’s oncology pipeline.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vidac Pharma Holding plc published the original content used to generate this news brief via pressetext (Ref. ID: 202602160100PRESSTXTEUPR____5870204DE1DE384988D7A85DDCB8E5F) on February 16, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}